Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma.
Saved in:
| Title: | Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma. |
|---|---|
| Authors: | Naranjo NM; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Kennedy A; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Testa A; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Verrillo CE; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Altieri AD; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Kean R; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Hooper DC; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA., Yu J; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Zhao J; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA., Abinader O; Division of Biostatistics and Bioinformatics, Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Pickles MW; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Hawkins A; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Kelly WK; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA., Mitra R; Division of Biostatistics and Bioinformatics, Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA., Languino LR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. |
| Source: | Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2364433. Date of Electronic Publication: 2024 Jun 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
